Hair Loss News and Research RSS Feed - Hair Loss News and Research

Image Wisely launches third radiation safety case

Image Wisely recently launched its third Image Wisely Radiation Safety Case — CT Brain Perfusion Dose Optimization. This is the latest in a series of free, online and mobile-compatible educational offerings, developed with the assistance of the American College of Radiology, that allow radiologists, imaging technologists and medical physicists to assess their understanding of important radiation safety concepts - including dose monitoring and optimization. [More]
Nanotechnology unlocks new pathways for targeted drug delivery

Nanotechnology unlocks new pathways for targeted drug delivery

​Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge. [More]

Restoration Robotics presents revolutionary robotic systems at Orlando Live Surgery Workshop

Restoration Robotics, Inc., the global leader in robotic hair transplantation, will have Craig Ziering, DO, present ARTAS Hair Studio™ and the ARTAS® Robotic System during the Platinum Orlando Live Surgery Workshop taking place April 9 through 12 in Orlando, FL. [More]
Molecular function of "hairless" gene may contribute to pathogenesis of atrichia with papular lesions

Molecular function of "hairless" gene may contribute to pathogenesis of atrichia with papular lesions

It's not a hair-brained idea: A new research report appearing in the April 2014 issue of The FASEB Journal explains why people with a rare balding condition called "atrichia with papular lesions" lose their hair, and it identifies a strategy for reversing this hair loss. [More]
Microencapsulated drug delivery may soon revolutionize cancer treatment

Microencapsulated drug delivery may soon revolutionize cancer treatment

Invasive and systemic cancer treatment is a necessary evil for many people with the devastating diagnosis. These patients endure therapies with ravaging side effects, including nausea, immune suppression, hair loss and even organ failure, in hopes of eradicating cancerous tissues in the body. [More]

Chemo and radiation can kill more cancer cells and spare healthy ones, suggests Rutgers research

What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer. [More]
Discovery opens door for more targeted treatments for cancer patients

Discovery opens door for more targeted treatments for cancer patients

Cancer patients could one day experience fewer side effects from chemotherapy following a discovery that opens the door for more targeted treatments. [More]
New approach for reversing hair loss uses stem cells to regenerate missing hair follicles

New approach for reversing hair loss uses stem cells to regenerate missing hair follicles

If the content of many a situation comedy, not to mention late-night TV advertisements, is to be believed, there's an epidemic of balding men, and an intense desire to fix their follicular deficiencies. [More]

Starpharma receives approvals to commence phase 1 human clinical trial for DEP-Docetaxel

Starpharma today announced that it has received the necessary approvals to commence a phase 1 human clinical trial for its dendrimer-enhanced docetaxel (Taxotere®) chemotherapeutic product, referred to as DEP™-Docetaxel. [More]
IQWiG study finds no added benefit of teriflunomide

IQWiG study finds no added benefit of teriflunomide

Teriflunomide (trade name: Aubagio) has been approved in Germany since August 2013 for adults with relapsing remitting multiple sclerosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA). [More]

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem. [More]

Methodology needed to diagnose quality of life of individual cancer patients or survivors

Due to improved treatments and technologies, more children than ever are surviving cancer. Unfortunately, about 70 percent of these children experience late effects from their disease and treatment 30 years after their cancer diagnosis, which University of Florida Health researchers say significantly impact their quality of life. [More]
Manipulation of Wnt/B-catenin pathway provides therapeutic targets for hair loss, skin cancer

Manipulation of Wnt/B-catenin pathway provides therapeutic targets for hair loss, skin cancer

​A pathway known for its role in regulating adult stem cells has been shown to be important for hair follicle proliferation, but contrary to previous studies, is not required within hair follicle stem cells for their survival, according to researchers with the Perelman School of Medicine at the University of Pennsylvania. [More]
Researchers identify new mechanism that causes neurodegeneration

Researchers identify new mechanism that causes neurodegeneration

As we age, our body rhythms lose time before they finally stop. Breaking the body clock by genetically disrupting a core clock gene, Bmal1, in mice has long been known to accelerate aging , causing arthritis, hair loss, cataracts, and premature death. [More]
Dermatologist offers tips for healthy hair when using hair treatments

Dermatologist offers tips for healthy hair when using hair treatments

While coloring your hair is a common beauty treatment, the process can leave your hair dry and brittle. Fortunately, dermatologists, who are experts in the care of the skin, hair and nails, offer tips for coloring and perming your hair while keeping it healthy. [More]
Lupus disparities: Young, black women have highest rate of developing lupus

Lupus disparities: Young, black women have highest rate of developing lupus

Young, black women have the highest rate of developing lupus and are most likely to be diagnosed at a younger age than whites and during childbearing years, according to a new University of Michigan study of lupus in Southeastern Michigan. [More]
CUMC develops new technique that uses patient's own cells to grow new hair

CUMC develops new technique that uses patient's own cells to grow new hair

​Researchers at Columbia University Medical Center (CUMC) have devised a hair restoration method that can generate new human hair growth, rather than simply redistribute hair from one part of the scalp to another. [More]

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein. [More]

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer. [More]
Messages that warn consumers about potentially harmful side effects increase product sales

Messages that warn consumers about potentially harmful side effects increase product sales

Drug ads often warn of serious side effects, from nausea and bleeding to blindness, even death. New research suggests that, rather than scaring consumers away, these warnings can improve consumers' opinions and increase product sales when there is a delay between seeing the ad and deciding to buy or consume the product. [More]